Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: HS-10352
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.